Insilico Modelling and Comparative Docking Studies of EWS-FLI1 Responsible for Ewing Sarcoma in Human Beings
Abstract
Ewing’s sarcoma (EWS) is a small round-cell tumor typically arising in the bones, rarely in soft tissues, of children and adolescents. Patho-genomic translocations involving the EWS gene on chromosome 22 and an ETS-type gene (Fli1) on chromosome 11, are implicated in more than 95% of Ewing’s sarcomas. A chimeric transcript that consists of the N-terminus of EWS i.e., Transcriptional Activation Domain is fused to the C-terminal portion of FLI1 i.e., DNA Binding Domain (DBD). In this present study, the structure of disordered fusion protein, EWS-FLI1 was predicted, modelled and refined. Ligand structures were drawn by using CHEMDRAW and CORINA. Comparative Docking studies were performed for EWS-FLI1 protein with EMODIN and YK-4-279 by using SCHRODINGER. Although, EMODIN and YK-4-279 interacted with the protein by establishing the H-Bonds with SER 316, GLN 326, GLN 328, ASP 430 by the former and with SER 316, ALA 110, and GLN 109 with the later, a common residue of SER 316 was observed to be interacting. However, the docking score and Glide g score of -6.278203 and -6.100573 were observed for EMODIN and YK-4-279 respectively, which revealed EMODIN to be much more effective in presenting the highest value. Molecular Dynamics Simulation was performed to analyse the stability of Docked structure of protein and ligand. For EMODIN, the stabilized structure was formed at 646 ps whereas for YK-4-279, the stabilized structure was formed at 680 ps and RMSD values for EMODIN was comparatively lower than YK-4-279.
Keywords: Ewing sarcoma, disordered fusion protein, natural ligand, comparison, molecular dynamic simulation
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information:
Name:
Address:
E-mail:
Contact Number:
It is herein agreed that:
The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.
I/We also agree to the authorship of the article in the following order:
Author(s) Name Signature(s)
1. ________________
2. ________________
3. ________________
4. ________________
The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).